CAMS Therapy for Suicidal Thoughts

This trial explores brain function in young people with suicidal thoughts and behaviors. Researchers aim to understand brain changes in individuals at varying suicide risk levels and assess how a specific therapy, called CAMS (Collaborative Assessment and Management of Suicidality), might help. CAMS involves working closely with a therapist to address the reasons behind suicidal thoughts. The trial seeks participants aged 14-24 who have recently attempted suicide, have experienced suicidal thoughts for a year, or have no history of suicidal thoughts or actions. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could improve mental health treatments for young people.

The trial protocol does not specify whether you need to stop taking your current medications. However, if you are taking amphetamines for ADHD, you will not be excluded from the study.

Previous studies have shown that CAMS therapy quickly and effectively reduces suicidal thoughts for an extended period. Research indicates that CAMS not only lowers these thoughts but also reduces overall distress and related risk factors. Importantly, CAMS is well-tolerated and often leads to better treatment outcomes compared to other methods. Participants in these studies generally did not report any serious side effects, suggesting that CAMS is a safe treatment option for those struggling with suicidal thoughts.¹²³⁴⁵

Researchers are excited about the CAMS Therapy for suicidal thoughts because it offers a personalized approach to managing suicidality, different from typical treatments like medication or generalized therapy. This method involves collaborative assessment and management, where patients actively participate in identifying and addressing their suicidal thoughts and behaviors. This direct involvement can lead to more tailored and effective interventions, potentially improving outcomes and providing a sense of empowerment for patients. By focusing on understanding the individual’s specific issues and developing a personalized treatment plan, CAMS could revolutionize how we approach and treat suicidal ideation.

Research has shown that the Collaborative Assessment and Management of Suicidality (CAMS) effectively reduces suicidal thoughts and distress. Studies have found that CAMS quickly and consistently lowers thoughts of suicide and overall distress from symptoms. Specifically, CAMS has outperformed other treatments, resulting in significantly lower levels of suicidal thoughts. Patients also experience better treatment outcomes and develop stronger relationships with their therapists. These findings suggest that CAMS offers a promising approach for helping individuals with suicidal thoughts. Participants in this trial will be categorized into high-risk, medium-risk, and minimal-risk groups to evaluate CAMS's effectiveness across varying levels of suicidal risk.¹²⁶⁷⁸